FitLife Brands Announces Q3 EPS of 9 Cents Compared to 21 Cents Last Year
Reports Q3 revenue $23.485M vs $15.977M last year. Dayton Judd, the Company's Chairman and CEO commented, "Although we are still working through the previously disclosed challenges associated with our MRC business, we are very encouraged by the performance of our other brands during the third quarter of 2025, with MusclePharm organic revenue increasing 55% and Legacy FitLife organic revenue excluding MRC increasing 8%. On a year-to-date basis, MusclePharm and Legacy FitLife excluding MRC have delivered organic revenue growth of 15% and 7%, respectively."
